These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25915825)

  • 21. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.
    Ballabio E; Mitchell T; van Kester MS; Taylor S; Dunlop HM; Chi J; Tosi I; Vermeer MH; Tramonti D; Saunders NJ; Boultwood J; Wainscoat JS; Pezzella F; Whittaker SJ; Tensen CP; Hatton CS; Lawrie CH
    Blood; 2010 Aug; 116(7):1105-13. PubMed ID: 20448109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ability of versican to simultaneously cause apoptotic resistance and sensitivity.
    LaPierre DP; Lee DY; Li SZ; Xie YZ; Zhong L; Sheng W; Deng Z; Yang BB
    Cancer Res; 2007 May; 67(10):4742-50. PubMed ID: 17510402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
    Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.
    Rozati S; Cheng PF; Widmer DS; Fujii K; Levesque MP; Dummer R
    Clin Cancer Res; 2016 Apr; 22(8):2020-31. PubMed ID: 26660520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo.
    Keire PA; Bressler SL; Mulvihill ER; Starcher BC; Kang I; Wight TN
    Matrix Biol; 2016 Mar; 50():67-81. PubMed ID: 26723257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sézary Syndrome: Clinical and Biological Aspects.
    Kohnken R; Fabbro S; Hastings J; Porcu P; Mishra A
    Curr Hematol Malig Rep; 2016 Dec; 11(6):468-479. PubMed ID: 27704468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican.
    Zhang Z; Zhang J; Miao L; Liu K; Yang S; Pan C; Jiao B
    Int J Biol Sci; 2012; 8(3):383-93. PubMed ID: 22393310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis.
    Asano K; Nelson CM; Nandadasa S; Aramaki-Hattori N; Lindner DJ; Alban T; Inagaki J; Ohtsuki T; Oohashi T; Apte SS; Hirohata S
    Sci Rep; 2017 Dec; 7(1):17225. PubMed ID: 29222454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and regulation of versican in neural precursor cells and their lineages.
    Gu WL; Fu SL; Wang YX; Li Y; Wang XF; Xu XM; Lu PH
    Acta Pharmacol Sin; 2007 Oct; 28(10):1519-30. PubMed ID: 17883936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
    Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
    Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription.
    Wang Y; Su M; Zhou LL; Tu P; Zhang X; Jiang X; Zhou Y
    Blood; 2011 Apr; 117(14):3826-35. PubMed ID: 21270445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
    Suda K; Tomizawa K; Fujii M; Murakami H; Osada H; Maehara Y; Yatabe Y; Sekido Y; Mitsudomi T
    J Thorac Oncol; 2011 Jul; 6(7):1152-61. PubMed ID: 21597390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids.
    Oktem G; Sercan O; Guven U; Uslu R; Uysal A; Goksel G; Ayla S; Bilir A
    Oncol Rep; 2014 Aug; 32(2):641-9. PubMed ID: 24927163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TOX expression in different subtypes of cutaneous lymphoma.
    Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.
    Chen CN; Chang CC; Su TE; Hsu WM; Jeng YM; Ho MC; Hsieh FJ; Lee PH; Kuo ML; Lee H; Chang KJ
    Ann Surg Oncol; 2009 Feb; 16(2):524-33. PubMed ID: 19050968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NFATc1 as a therapeutic target in FLT3-ITD-positive AML.
    Metzelder SK; Michel C; von Bonin M; Rehberger M; Hessmann E; Inselmann S; Solovey M; Wang Y; Sohlbach K; Brendel C; Stiewe T; Charles J; Ten Haaf A; Ellenrieder V; Neubauer A; Gattenlöhner S; Bornhäuser M; Burchert A
    Leukemia; 2015 Jul; 29(7):1470-7. PubMed ID: 25976987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
    Wu J; Nihal M; Siddiqui J; Vonderheid EC; Wood GS
    J Invest Dermatol; 2009 May; 129(5):1165-73. PubMed ID: 18923451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.